期刊文献+

血液灌流治疗对脓毒症急性肾损伤患者炎症因子的清除及肾脏保护作用 被引量:45

Removal of inflammatory cytokines by hemoperfusion for protecting the kidney from acute injury in patients with sepsis
原文传递
导出
摘要 目的 探讨血液灌流(hemoperfusion,HP)治疗对重症脓毒症急性肾损伤(acute lung injury,AKI)患者体内炎症因子的清除及对肾功能的保护作用.方法 本研究为前瞻、对照研究,选取40例2007年至2009年广州市第一人民医院ICU住院脓毒症及急性肾损伤患者进行随机分组.其中22例接受血液灌流治疗,每次2 h,连续3 d,采用珠海丽珠公司HA330型大孔径中性树脂灌流器;18例仅接受常规治疗.所有患者均于治疗前,治疗3 d,7 d及14 d分别抽血检测IL-6,IL-10的水平,及C反应蛋白水平,并记录24 h尿量,Scr及相关肾小管功能指标.结果 与对照组相比,HP治疗组患者治疗后血浆CRP及IL-6IL-10水平明显下降(P<0.05),同时尿量显著增加,尿N,乙酰-B-氨基葡萄糖苷酶(NAG),γ-GTP,α1-微球蛋白及血BUN,Scr水平均明显低于对照组(P<0.05).此外,AKI患者Ⅰ、Ⅱ期接受血液灌流治疗的患者肾功能恢复率及生存率均高于对照组(P<0.05).两组患者治疗前后血流动力学改变,如平均动脉压水平差异均无统计学意义(P>0.05).结论 血液灌流早期治疗脓毒症急性肾损伤患者可能通过有效清除炎症因子起到保护肾小管及促进肾功能恢复的作用. Objective To study the protective effect of removing inflammatory cytokines by hemoperfusion (HP)on acute kidney injury (AKI) in patients with sepsis. Method A total of 40 patients with sepsis and AKI were randomly divided into two croups: HP treatment group (n = 22) and control group (n = 18). Hemoperfusion carried out in patients of Hp group with HA330 filter once a day for 3 days and the procedure of each hemoperfusion was completed in 2 hours. The patients of control group were treated with routine treatment. Further, the hemodynamics, plasma IL-6, IL-10, C-reactive protein (CRP), serum creatinine (Scr), blood BUN and urine NAG, γ-GTP,α1-MG of patients in both groups were detected before treatment and 3 d,7 d and 14 days after treatment. Results Compared to control group, the levels of plasma interleukins-6, IL-10 and C-reactive protein were significantly lower (P 〈 0.05), along with increase in urine output, lower levels of blood BUN and Scr, reduction in urine NAG,γ-GT and α1-MG (P 〈 0.05). In addition, the patients at Ⅰ or Ⅱ stage of AKI treated with hemoperfusion had significantly lower level of Scr in 14 days and lower mortality in intensive care unit in comparison with control group (P 〈 0.05). Conclusions Hemoperfusion employed in the earlier stage of AKI with the HA type filter may have protective effect on acute kidney injury by the removal of inflammatory cytokines in the setting of sepsis.
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2011年第1期60-64,共5页 Chinese Journal of Emergency Medicine
关键词 血液净化 血液灌流 脓毒症 急性肾损伤 细胞因子 血流动力学 肾功能 生存率 Blood purification Hemoperfusion Sepsis Acute kidney injury Cytokine Hemodynamics Renal function Survival rate
  • 相关文献

参考文献15

  • 1姚咏明,盛志勇.重视对脓毒症本质的探讨[J].中华急诊医学杂志,2005,14(3):185-186. 被引量:118
  • 2Bone RC,Grodzin CJ,Balk RA.Sepsis:a new hypothesis for pathogenesis of the disease process[J].Chest,1997,112 (1):235-243.
  • 3Bagshaw SM,Uchino S,Belomo R,et al.Septic acute kidney injury in critically ill patients:clinical characteristics and outcomes[J].Clin J Am Soc Nephrul,2007,2(9):431-439.
  • 4Molitoris BA,Levin A,Warnock DG,et al.Acute kidney injury netowok:improving outcomes form acute kidney injury[J].J Am Soc Nephrol,2007,18(4):1992-1994.
  • 5Mehta RL,Pascual MT,Soroko S,et al.Sectrum of acute renal failure in the intensive care unit:The PICARD experience[J].Kidney Int,2004,66(3):1613-1621.
  • 6黎磊石,刘志红.连续性血液净化:一种协助重建机体免疫内稳状态的技术?[J].肾脏病与透析肾移植杂志,2003,12(1):1-1. 被引量:106
  • 7Flierl MA,Schreiber H,Huber-Lang MS.The role of complement,C5a and its receptors in sepsis and multiorgan dysfunction syndrome[J].J Invest Surg,2006,19(4):1448.
  • 8Cho KC,Himmclfarb J,Paganini E,et al.Survival by dialysis modality in critically ill patients with acute kidney injury[J].J Am Soc Nephrol,2006,17(11):3132-3138.
  • 9Haase-Fielitz A,Hasse M,Belloma R,et al.Genetic polymorphisms in sepsis-and cardiopulmonary bypass-associated acute kidney injury.In:Ronco C,Bellomo R,Kellum JA eds.Acute kidney injury.Contrib Nephrol[J].Basel:Karger,2007,156(1):75-91.
  • 10余晨,刘志红,陈朝红,龚德华,季大玺,黎磊石.连续性血液净化对血浆细胞因子水平的影响及其清除机制[J].肾脏病与透析肾移植杂志,2004,13(5):401-407. 被引量:68

二级参考文献30

  • 1邢金燕,韩小宁,孙运波,栾敏,杜春艳.乌司他丁对重度脓毒症患者淋巴细胞亚群的影响[J].中华急诊医学杂志,2006,15(5):441-443. 被引量:19
  • 2李文华,宋志芳,单慧敏.乌司他丁对脓毒症大鼠肺损伤的保护作用[J].中华急诊医学杂志,2007,16(2):132-137. 被引量:23
  • 3周建明,刘志勇,贾辉.乌司他丁对犬肺缺血再灌注损伤的保护作用[J].江苏医药,2007,33(4):378-380. 被引量:5
  • 4[1]Hirassawa H, Sugai T, Oda S, et al. Continous hemodiafiltration can remove humoral mediators from the blood stream of patients with SIRS/MODS. Abstr. Blood Purif,1997, 15:136
  • 5[2]Heering P, Morgera S, Schmitz G, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med, 1997, 23:288
  • 6[3]Kouche K,Cavadore P,Portales P, et al. Continous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNF-α and IL-6 plasma concentrations. J Neprol, 2002, 15:150
  • 7[4]Sander A,Armbruster W,Sander B, et al. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but not alter IL-6 and TNF-α plasma concentrations. Intensive Care Med, 1997, 23:878
  • 8[6]Sieberth HG,Kierdorf HP. Is cytokine removal by continuous hemofiltration feasible? Kidney Int. 1999, 56(Suppl. 72): S79
  • 9[7]Silvester W. Mediator removal with CRRT: complement and cytokines. Am J Kidney Dis, 1997, 30 (Suppl.4): S38
  • 10[8]Sibbald WJ, Vincent JL. Round table conference on clinical trial for the treatment of sepsis. Crit Care Med, 1995, 23:394

共引文献328

同被引文献355

引证文献45

二级引证文献351

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部